Olanzapine Lekam (Olanzapine)

Olanzapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors, while also affecting other neurotransmitter systems such as 5‑HT2C, histamine H1, muscarinic, and α1‑adrenergic receptors. This broad antagonism helps to reduce psychotic symptoms and stabilize mood.

The appropriate dose of Olanzapine Lekam is individualized by the prescribing clinician based on the patient’s diagnosis, severity of symptoms, prior treatment response, and tolerability. Dosage adjustments are made under medical supervision.

Olanzapine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so breastfeeding is generally not recommended unless the infant’s need for the medication outweighs the possible adverse effects.

To order Olanzapine Lekam, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other atypical antipsychotics such as risperidone, olanzapine generally offers strong efficacy for both psychotic and mood symptoms but has a higher propensity for metabolic side effects like weight gain and glucose intolerance. Choice of therapy depends on individual patient factors and risk‑benefit considerations.

Olanzapine Lekam tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity.

Olanzapine Lekam is taken orally as a tablet. The tablet should be swallowed whole with water and can be taken with or without food, according to the prescribing clinician’s instructions.

Serious risks include metabolic syndrome (significant weight gain, hyperglycemia, dyslipidemia), neuroleptic malignant syndrome, tardive dyskinesia, and severe hyperglycemia. Patients should be monitored regularly for these conditions, and any concerning symptoms should be reported promptly.

Olanzapine Lekam is contraindicated in patients with known hypersensitivity to olanzapine or any excipients, and in individuals with severe central nervous system depression. Caution is advised in patients with uncontrolled diabetes, cardiovascular disease, or a history of neuroleptic malignant syndrome.